Robin Smith
2012
In 2012, Robin Smith earned a total compensation of $1.6M as Chief Executive Officer at Caladrius Biosciences, a 55% decrease compared to previous year.
Compensation breakdown
| Bonus | $363,000 |
|---|---|
| Option Awards | $638,941 |
| Salary | $412,694 |
| Stock Awards | $183,840 |
| Other | $44,927 |
| Total | $1,643,403 |
Smith received $638.9K in option awards, accounting for 39% of the total pay in 2012.
Smith also received $363K in bonus, $412.7K in salary, $183.8K in stock awards and $44.9K in other compensation.
Rankings
In 2012, Robin Smith's compensation ranked 4,224th out of 11,487 executives tracked by ExecPay. In other words, Smith earned more than 63.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,224 out of 11,487 | 63rd |
Division Manufacturing | 1,469 out of 4,253 | 66th |
Major group Chemicals And Allied Products | 332 out of 1,198 | 72nd |
Industry group Drugs | 202 out of 920 | 78th |
Industry Pharmaceutical Preparations | 155 out of 700 | 78th |
Source: SEC filing on August 30, 2013.
Smith's colleagues
We found two more compensation records of executives who worked with Robin Smith at Caladrius Biosciences in 2012.